MARKET

EOLS

EOLS

Evolus
NASDAQ
6.81
+0.01
+0.15%
After Hours: 6.81 0 0.00% 19:30 11/06 EST
OPEN
6.74
PREV CLOSE
6.80
HIGH
6.92
LOW
6.57
VOLUME
1.52M
TURNOVER
--
52 WEEK HIGH
9.31
52 WEEK LOW
3.860
MARKET CAP
449.47M
P/E (TTM)
-12.9152
1D
5D
1M
3M
1Y
5Y
1D
Evolus (EOLS) Gets a Buy from Leerink Partners
TipRanks · 3d ago
Stifel Nicolaus Remains a Buy on Evolus (EOLS)
TipRanks · 3d ago
Evolus Is Maintained at Buy by BTIG
Dow Jones · 3d ago
Evolus Price Target Raised to $15.00/Share From $13.00 by BTIG
Dow Jones · 3d ago
BTIG Maintains Buy on Evolus, Raises Price Target to $15
Benzinga · 3d ago
Evolus, Inc. Reports Third Quarter 2026 Global Net Revenue of $78.0 Million and Reaffirms Full-Year Revenue Guidance
NASDAQ · 3d ago
Press Release: Evolus Reports Third Quarter 2026 Financial Results with 13% Year-Over-Year Revenue Growth; Delivers Fourth Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year 2026 Financial Outlook
Dow Jones · 4d ago
Weekly Report: what happened at EOLS last week (1026-1030)?
Weekly Report · 6d ago
More
About EOLS
Evolus, Inc. is a performance beauty company. Its primary market is the cash-pay aesthetic market, which consists of medical products. Its product candidates represent two of the product categories within medical aesthetics, injectable neurotoxins and injectable hyaluronic acid gels. Its product candidates include Jeuveau and Evolysse. Jeuveau is its commercially available proprietary 900 kilodalton (kDa), purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Jeuveau offers a 900kDa botulinum toxin alternative to BOTOX (onabotulinumtoxinA). Jeuveau is available in the United States, Canada, and certain European markets. Evolysse is a line of hyaluronic acid dermal fillers which utilizes first-generation cold technology. The line includes a variety of products, including mid face, nasolabial folds, lips and eyes in the United States and Europe.

Webull offers Evolus Inc stock information, including NASDAQ: EOLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EOLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EOLS stock methods without spending real money on the virtual paper trading platform.